Obesity and Placental Function

Seminars in Reproductive Medicine

Volumn 34, Issue 1, 2016, Pages 42-49

  Myatt, Leslie ^b   Maloyan, Alina ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

epigenetics; inflammation; mitochondria; obesity; oxidative stress; placenta

Indexed keywords

ADENOSINE TRIPHOSPHATE; FATTY ACID;

ARTICLE; EPIGENETICS; FEMALE; FETUS OUTCOME; HUMAN; INFLAMMATION; LIPID TRANSPORT; MATERNAL METABOLISM; MATERNAL NUTRITION; MATERNAL OBESITY; METABOLISM; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; NITRATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PLACENTA; PLACENTA FUNCTION; PLACENTAL METABOLISM; PLACENTAL MITOCHONDRION; PRENATAL DEVELOPMENT; SEX DIFFERENCE; TROPHOBLAST; UTERUS; ANIMAL; COMPLICATION; FETOMATERNAL TRANSFUSION; FETUS DEVELOPMENT; GENETIC EPIGENESIS; HYPERLIPIDEMIA; LIPID METABOLISM; MALE; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PLACENTA DISEASES; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; SEXUAL DEVELOPMENT;

ANIMALS; EPIGENESIS, GENETIC; FATTY ACIDS, NONESTERIFIED; FEMALE; FETAL DEVELOPMENT; HUMANS; HYPERLIPIDEMIAS; INFLAMMATION; LIPID METABOLISM; MALE; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; MATERNAL-FETAL EXCHANGE; MITOCHONDRIA; OBESITY; OXIDATIVE STRESS; PLACENTA; PLACENTA DISEASES; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; SEX CHARACTERISTICS; TROPHOBLASTS;

EID: 84956589930     PISSN: 15268004     EISSN: 15264564     Source Type: Journal    
DOI: 10.1055/s-0035-1570027     Document Type: Article

References (121)

1. Yogev Y., Catalano P. M. Pregnancy and obesity. Obstet Gynecol Clin North Am: 2009; 36 2 285 300, viii
2. Trasande L., Lee M., Liu Y., Weitzman M., Savitz D. Incremental charges, costs, and length of stay associated with obesity as a secondary diagnosis among pregnant women. Med Care: 2009; 47 10 1046 1052
3. Reece E. A. Obesity, diabetes, and links to congenital defects: a review of the evidence and recommendations for intervention. J Matern Fetal Neonatal Med: 2008; 21 3 173 180
4. Vasudevan C., Renfrew M., McGuire W. Fetal and perinatal consequences of maternal obesity. Arch Dis Child Fetal Neonatal Ed: 2011; 96 5 F378 F382
5. Baeten J. M., Bukusi E. A., Lambe M. Pregnancy complications and outcomes among overweight and obese nulliparous women. Am J Public Health: 2001; 91 3 436 440
6. Sebire N. J., Jolly M., Harris J. P., et al. Maternal obesity and pregnancy outcome: a study of 287,213 pregnancies in London. Int J Obes Relat Metab Disord: 2001; 25 8 1175 1182
7. Wou K., Ouellet M. P., Chen M. F., Brown R. N. Comparison of the aetiology of stillbirth over five decades in a single centre: a retrospective study. BMJ Open: 2014; 4 6 e004635
8. Yao R., Ananth C. V., Park B. Y., Pereira L., Plante L. A.; Perinatal Research Consortium. Obesity and the risk of stillbirth: a population-based cohort study. Am J Obstet Gynecol: 2014; 210 5 457.e1 457.e9
9. Aune D., Saugstad O. D., Henriksen T., Tonstad S. Maternal body mass index and the risk of fetal death, stillbirth, and infant death: a systematic review and meta-analysis. JAMA: 2014; 311 15 1536 1546
10. Ehrenberg H. M., Durnwald C. P., Catalano P., Mercer B. M. The influence of obesity and diabetes on the risk of cesarean delivery. Am J Obstet Gynecol: 2004; 191 3 969 974
11. Watkins M. L., Botto L. D. Maternal prepregnancy weight and congenital heart defects in offspring. Epidemiology: 2001; 12 4 439 446
12. Ehrenberg H. M., Mercer B. M., Catalano P. M. The influence of obesity and diabetes on the prevalence of macrosomia. Am J Obstet Gynecol: 2004; 191 3 964 968
13. Kim C., Newton K. M., Knopp R. H. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care: 2002; 25 10 1862 1868
14. Myatt L. Placental adaptive responses and fetal programming. J Physiol: 2006; 572 Pt 1 25 30
15. Liguori A., D'Armiento F. P., Palagiano A., et al. Effect of gestational hypercholesterolaemia on omental vasoreactivity, placental enzyme activity and transplacental passage of normal and oxidised fatty acids. BJOG: 2007; 114 12 1547 1556
16. Barker D. J. The origins of the developmental origins theory. J Intern Med: 2007; 261 5 412 417
17. Barker D. J., Bagby S. P., Hanson M. A. Mechanisms of disease: in utero programming in the pathogenesis of hypertension. Nat Clin Pract Nephrol: 2006; 2 12 700 707
18. Chu S. Y., Kim S. Y., Lau J., et al. Maternal obesity and risk of stillbirth: a metaanalysis. Am J Obstet Gynecol: 2007; 197 3 223 228
19. Frias A. E., Morgan T. K., Evans A. E., et al. Maternal high-fat diet disturbs uteroplacental hemodynamics and increases the frequency of stillbirth in a nonhuman primate model of excess nutrition. Endocrinology: 2011; 152 6 2456 2464
20. Rogers L. K., Velten M. Maternal inflammation, growth retardation, and preterm birth: insights into adult cardiovascular disease. Life Sci: 2011; 89 13-14 417 421
21. Clifton V. L. Review: Sex and the human placenta: mediating differential strategies of fetal growth and survival. Placenta: 2010; 31 (Suppl): S33 S39
22. Eriksson J. G., Kajantie E., Osmond C., Thornburg K., Barker D. J. Boys live dangerously in the womb. Am J Hum Biol: 2010; 22 3 330 335
23. Stark M. J., Wright I. M., Clifton V. L. Sex-specific alterations in placental 11beta-hydroxysteroid dehydrogenase 2 activity and early postnatal clinical course following antenatal betamethasone. Am J Physiol Regul Integr Comp Physiol: 2009; 297 2 R510 R514
24. Sood R., Zehnder J. L., Druzin M. L., Brown P. O. Gene expression patterns in human placenta. Proc Natl Acad Sci U S A: 2006; 103 14 5478 5483
25. Scott N. M., Hodyl N. A., Murphy V. E., et al. Placental cytokine expression covaries with maternal asthma severity and fetal sex. J Immunol: 2009; 182 3 1411 1420
26. Osei-Kumah A., Smith R., Jurisica I., Caniggia I., Clifton V. L. Sex-specific differences in placental global gene expression in pregnancies complicated by asthma. Placenta: 2011; 32 8 570 578
27. Mao J., Zhang X., Sieli P. T., Falduto M. T., Torres K. E., Rosenfeld C. S. Contrasting effects of different maternal diets on sexually dimorphic gene expression in the murine placenta. Proc Natl Acad Sci U S A: 2010; 107 12 5557 5562
28. Yeganegi M., Leung C. G., Martins A., et al. Lactobacillus rhamnosus GR-1 stimulates colony-stimulating factor 3 (granulocyte) (CSF3) output in placental trophoblast cells in a fetal sex-dependent manner. Biol Reprod: 2011; 84 1 18 25
29. Steier J. A., Ulstein M., Myking O. L. Human chorionic gonadotropin and testosterone in normal and preeclamptic pregnancies in relation to fetal sex. Obstet Gynecol: 2002; 100 3 552 556
30. Sathishkumar K., Balakrishnan M., Chinnathambi V., Chauhan M., Hankins G. D., Yallampalli C. Fetal sex-related dysregulation in testosterone production and their receptor expression in the human placenta with preeclampsia. J Perinatol: 2012; 32 5 328 335
31. Díaz L., Noyola-Martínez N., Barrera D., et al. Calcitriol inhibits TNF-alpha-induced inflammatory cytokines in human trophoblasts. J Reprod Immunol: 2009; 81 1 17 24
32. Jiang B., Kamat A., Mendelson C. R. Hypoxia prevents induction of aromatase expression in human trophoblast cells in culture: potential inhibitory role of the hypoxia-inducible transcription factor Mash-2 (mammalian achaete-scute homologous protein-2). Mol Endocrinol: 2000; 14 10 1661 1673
33. Acromite M. T., Mantzoros C. S., Leach R. E., Hurwitz J., Dorey L. G. Androgens in preeclampsia. Am J Obstet Gynecol: 1999; 180 1, Pt 1 60 63
34. Christensen A., Froyshov D., Fylling P. Hormone and enzyme assays in pregnancy. IV. The human chorionic somatomammotrophin, placental cystine-aminopeptidase, progesterone and the urinary oestrogens in pregnancies complicated with essential hypertension, mild or severe pre-eclampsia. Acta Endocrinol (Copenh): 1974; 77 2 344 355
35. Stewart F. M., Freeman D. J., Ramsay J. E., Greer I. A., Caslake M., Ferrell W. R. Longitudinal assessment of maternal endothelial function and markers of inflammation and placental function throughout pregnancy in lean and obese mothers. J Clin Endocrinol Metab: 2007; 92 3 969 975
36. Basu S., Haghiac M., Surace P., et al. Pregravid obesity associates with increased maternal endotoxemia and metabolic inflammation. Obesity (Silver Spring): 2011; 19 3 476 482
37. Aye I. L., Lager S., Ramirez V. I., et al. Increasing maternal body mass index is associated with systemic inflammation in the mother and the activation of distinct placental inflammatory pathways. Biol Reprod: 2014; 90 6 129
38. Roberts K. A., Riley S. C., Reynolds R. M., et al. Placental structure and inflammation in pregnancies associated with obesity. Placenta: 2011; 32 3 247 254
39. Pathmaperuma A. N., Maña P., Cheung S. N., et al. Fatty acids alter glycerolipid metabolism and induce lipid droplet formation, syncytialisation and cytokine production in human trophoblasts with minimal glucose effect or interaction. Placenta: 2010; 31 3 230 239
40. Roberts V. H., Smith J., McLea S. A., Heizer A. B., Richardson J. L., Myatt L. Effect of increasing maternal body mass index on oxidative and nitrative stress in the human placenta. Placenta: 2009; 30 2 169 175
41. Aye I. L., Waddell B. J., Mark P. J., Keelan J. A. Oxysterols exert proinflammatory effects in placental trophoblasts via TLR4-dependent, cholesterol-sensitive activation of NF-κB. Mol Hum Reprod: 2012; 18 7 341 353
42. Challier J. C., Basu S., Bintein T., et al. Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta. Placenta: 2008; 29 3 274 281
43. Kelley D. E., He J., Menshikova E. V., Ritov V. B. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes: 2002; 51 10 2944 2950
44. Lager S., Jansson N., Olsson A. L., Wennergren M., Jansson T., Powell T. L. Effect of IL-6 and TNF-α on fatty acid uptake in cultured human primary trophoblast cells. Placenta: 2011; 32 2 121 127
45. Zhu M. J., Du M., Nathanielsz P. W., Ford S. P. Maternal obesity up-regulates inflammatory signaling pathways and enhances cytokine expression in the mid-gestation sheep placenta. Placenta: 2010; 31 5 387 391
46. Muralimanoharan S., Guo C., Myatt L., Maloyan A. Sexual dimorphism in miR-210 expression and mitochondrial dysfunction in the placenta with maternal obesity. Int J Obes: 2015; 39 8 1274 1281
47. Ghio A., Bertolotto A., Resi V., Volpe L., Di Cianni G. Triglyceride metabolism in pregnancy. Adv Clin Chem: 2011; 55 133 153
48. Catalano P. M., Huston L., Amini S. B., Kalhan S. C. Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am J Obstet Gynecol: 1999; 180 4 903 916
49. Aviram A., Hod M., Yogev Y. Maternal obesity: implications for pregnancy outcome and long-term risks-a link to maternal nutrition. Int J Gynaecol Obstet: 2011; 115 01 S6 S10
50. Carter A. M. Placental oxygen consumption. Part I: in vivo studies - a review. Placenta: 2000; 21 (Suppl A): S31 S37
51. Jones C. T., Rolph T. P. Metabolism during fetal life: a functional assessment of metabolic development. Physiol Rev: 1985; 65 2 357 430
52. Bloxam D. L., Bobinski P. M. Energy metabolism and glycolysis in the human placenta during ischaemia and in normal labour. Placenta: 1984; 5 5 381 394
53. Shekhawat P., Bennett M. J., Sadovsky Y., Nelson D. M., Rakheja D., Strauss A. W. Human placenta metabolizes fatty acids: implications for fetal fatty acid oxidation disorders and maternal liver diseases. Am J Physiol Endocrinol Metab: 2003; 284 6 E1098 E1105
54. Oey N. A., den Boer M. E., Ruiter J. P., et al. High activity of fatty acid oxidation enzymes in human placenta: implications for fetal-maternal disease. J Inherit Metab Dis: 2003; 26 4 385 392
55. Shulman G. I. Cellular mechanisms of insulin resistance. J Clin Invest: 2000; 106 2 171 176
56. Bartha J. L., Visiedo F., Fernández-Deudero A., Bugatto F., Perdomo G. Decreased mitochondrial fatty acid oxidation in placentas from women with preeclampsia. Placenta: 2012; 33 2 132 134
57. Håversen L., Danielsson K. N., Fogelstrand L., Wiklund O. Induction of proinflammatory cytokines by long-chain saturated fatty acids in human macrophages. Atherosclerosis: 2009; 202 2 382 393
58. Lambertucci R. H., Hirabara S. M., Silveira LdosR, Levada-Pires A. C., Curi R., Pithon-Curi T. C. Palmitate increases superoxide production through mitochondrial electron transport chain and NADPH oxidase activity in skeletal muscle cells. J Cell Physiol: 2008; 216 3 796 804
59. Metzger B. E., Persson B., Lowe L. P., et al. HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcome study: neonatal glycemia. Pediatrics: 2010; 126 6 e1545 e1552
60. Whyte K., Kelly H., O'Dwyer V., Gibbs M., O'Higgins A., Turner M. J. Offspring birth weight and maternal fasting lipids in women screened for gestational diabetes mellitus (GDM). Eur J Obstet Gynecol Reprod Biol: 2013; 170 1 67 70
61. Xu Y., Wang Q., Cook T. J., Knipp G. T. Effect of placental fatty acid metabolism and regulation by peroxisome proliferator activated receptor on pregnancy and fetal outcomes. J Pharm Sci: 2007; 96 10 2582 2606
62. Storch J., Corsico B. The emerging functions and mechanisms of mammalian fatty acid-binding proteins. Annu Rev Nutr: 2008; 28 73 95
63. Furuhashi M., Hotamisligil G. S. Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov: 2008; 7 6 489 503
64. Biron-Shental T., Schaiff W. T., Ratajczak C. K., Bildirici I., Nelson D. M., Sadovsky Y. Hypoxia regulates the expression of fatty acid-binding proteins in primary term human trophoblasts. Am J Obstet Gynecol: 2007; 197 5 516.e1 516.e6
65. Scifres C. M., Chen B., Nelson D. M., Sadovsky Y. Fatty acid binding protein 4 regulates intracellular lipid accumulation in human trophoblasts. J Clin Endocrinol Metab: 2011; 96 7 E1083 E1091
66. Shi H., Kokoeva M. V., Inouye K., Tzameli I., Yin H., Flier J. S. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest: 2006; 116 11 3015 3025
67. Llurba E., Gratacós E., Martín-Gallán P., Cabero L., Dominguez C. A comprehensive study of oxidative stress and antioxidant status in preeclampsia and normal pregnancy. Free Radic Biol Med: 2004; 37 4 557 570
68. Watson A. L., Skepper J. N., Jauniaux E., Burton G. J. Susceptibility of human placental syncytiotrophoblastic mitochondria to oxygen-mediated damage in relation to gestational age. J Clin Endocrinol Metab: 1998; 83 5 1697 1705
69. Graziewicz M. A., Day B. J., Copeland W. C. The mitochondrial DNA polymerase as a target of oxidative damage. Nucleic Acids Res: 2002; 30 13 2817 2824
70. Seo J., Lee K. J. Post-translational modifications and their biological functions: proteomic analysis and systematic approaches. J Biochem Mol Biol: 2004; 37 1 35 44
71. Kossenjans W., Eis A., Sahay R., Brockman D., Myatt L. Role of peroxynitrite in altered fetal-placental vascular reactivity in diabetes or preeclampsia. Am J Physiol Heart Circ Physiol: 2000; 278 4 H1311 H1319
72. Lyall F., Gibson J. L., Greer I. A., Brockman D. E., Eis A. L., Myatt L. Increased nitrotyrosine in the diabetic placenta: evidence for oxidative stress. Diabetes Care: 1998; 21 10 1753 1758
73. Zamudio S., Kovalenko O., Vanderlelie J., et al. Chronic hypoxia in vivo reduces placental oxidative stress. Placenta: 2007; 28 8-9 846 853
74. Koeck T., Stuehr D. J., Aulak K. S. Mitochondria and regulated tyrosine nitration. Biochem Soc Trans: 2005; 33 Pt 6 1399 1403
75. Mele J., Muralimanoharan S., Maloyan A., Myatt L. Impaired mitochondrial function in human placenta with increased maternal adiposity. Am J Physiol Endocrinol Metab: 2014; 307 5 E419 E425
76. Lowell B. B., Shulman G. I. Mitochondrial dysfunction and type 2 diabetes. Science: 2005; 307 5708 384 387
77. Pieczenik S. R., Neustadt J. Mitochondrial dysfunction and molecular pathways of disease. Exp Mol Pathol: 2007; 83 1 84 92
78. Højlund K., Wrzesinski K., Larsen P. M., et al. Proteome analysis reveals phosphorylation of ATP synthase beta -subunit in human skeletal muscle and proteins with potential roles in type 2 diabetes. J Biol Chem: 2003; 278 12 10436 10442
79. Ritov V. B., Menshikova E. V., He J., Ferrell R. E., Goodpaster B. H., Kelley D. E. Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes. Diabetes: 2005; 54 1 8 14
80. Zurlo F., Lillioja S., Esposito-Del Puente A., et al. Low ratio of fat to carbohydrate oxidation as predictor of weight gain: study of 24-h RQ. Am J Physiol: 1990; 259 5, Pt 1 E650 E657
81. Goodpaster B. H., Theriault R., Watkins S. C., Kelley D. E. Intramuscular lipid content is increased in obesity and decreased by weight loss. Metabolism: 2000; 49 4 467 472
82. Ruggiero C., Ehrenshaft M., Cleland E., Stadler K. High-fat diet induces an initial adaptation of mitochondrial bioenergetics in the kidney despite evident oxidative stress and mitochondrial ROS production. Am J Physiol Endocrinol Metab: 2011; 300 6 E1047 E1058
83. Boudina S., Sena S., O'Neill B. T., Tathireddy P., Young M. E., Abel E. D. Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity. Circulation: 2005; 112 17 2686 2695
84. Chavin K. D., Yang S., Lin H. Z., et al. Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion. J Biol Chem: 1999; 274 9 5692 5700
85. Sparks L. M., Xie H., Koza R. A., et al. A high-fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle. Diabetes: 2005; 54 7 1926 1933
86. Inui M., Martello G., Piccolo S. MicroRNA control of signal transduction. Nat Rev Mol Cell Biol: 2010; 11 4 252 263
87. Chan Y. C., Banerjee J., Choi S. Y., Sen C. K. miR-210: the master hypoxamir. Microcirculation: 2012; 19 3 215 223
88. Muralimanoharan S., Maloyan A., Mele J., Guo C., Myatt L. G., Myatt L. MIR-210 modulates mitochondrial respiration in placenta with preeclampsia. Placenta: 2012; 33 10 816 823
89. Khera A., Vanderlelie J. J., Perkins A. V. Selenium supplementation protects trophoblast cells from mitochondrial oxidative stress. Placenta: 2013; 34 7 594 598
90. Panee J., Stoytcheva Z. R., Liu W., Berry M. J. Selenoprotein H is a redox-sensing high mobility group family DNA-binding protein that up-regulates genes involved in glutathione synthesis and phase II detoxification. J Biol Chem: 2007; 282 33 23759 23765
91. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev: 2002; 16 1 6 21
92. Petronis A. Human morbid genetics revisited: relevance of epigenetics. Trends Genet: 2001; 17 3 142 146
93. Alegría-Torres J. A., Baccarelli A., Bollati V. Epigenetics and lifestyle. Epigenomics: 2011; 3 3 267 277
94. Jones P. A., Takai D. The role of DNA methylation in mammalian epigenetics. Science: 2001; 293 5532 1068 1070
95. Rakyan V. K., Preis J., Morgan H. D., Whitelaw E. The marks, mechanisms and memory of epigenetic states in mammals. Biochem J: 2001; 356 Pt 1 1 10
96. Cedar H., Bergman Y. Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet: 2009; 10 5 295 304
97. Smith C. J., Ryckman K. K. Epigenetic and developmental influences on the risk of obesity, diabetes, and metabolic syndrome. Diabetes Metab Syndr Obes: 2015; 8 295 302
98. Weinmann A. S., Bartley S. M., Zhang T., Zhang M. Q., Farnham P. J. Use of chromatin immunoprecipitation to clone novel E2F target promoters. Mol Cell Biol: 2001; 21 20 6820 6832
99. Kimura A. P., Liebhaber S. A., Cooke N. E. Epigenetic modifications at the human growth hormone locus predict distinct roles for histone acetylation and methylation in placental gene activation. Mol Endocrinol: 2004; 18 4 1018 1032
100. Turner B. M. Cellular memory and the histone code. Cell: 2002; 111 3 285 291
101. Boyer L. A., Plath K., Zeitlinger J., et al. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature: 2006; 441 7091 349 353
102. Gagnidze K., Weil Z. M., Faustino L. C., Schaafsma S. M., Pfaff D. W. Early histone modifications in the ventromedial hypothalamus and preoptic area following oestradiol administration. J Neuroendocrinol: 2013; 25 10 939 955
103. Aagaard-Tillery K. M., Grove K., Bishop J., et al. Developmental origins of disease and determinants of chromatin structure: maternal diet modifies the primate fetal epigenome. J Mol Endocrinol: 2008; 41 2 91 102
104. Strakovsky R. S., Zhang X., Zhou D., Pan Y. X. Gestational high fat diet programs hepatic phosphoenolpyruvate carboxykinase gene expression and histone modification in neonatal offspring rats. J Physiol: 2011; 589 Pt 11 2707 2717
105. Nelissen E. C., van Montfoort A. P., Dumoulin J. C., Evers J. L. Epigenetics and the placenta. Hum Reprod Update: 2011; 17 3 397 417
106. Feinberg A. P., Tycko B. The history of cancer epigenetics. Nat Rev Cancer: 2004; 4 2 143 153
107. Chavan-Gautam P., Sundrani D., Pisal H., Nimbargi V., Mehendale S., Joshi S. Gestation-dependent changes in human placental global DNA methylation levels. Mol Reprod Dev: 2011; 78 3 150
108. Koukoura O., Sifakis S., Spandidos D. A. DNA methylation in the human placenta and fetal growth [review]. Mol Med Rep: 2012; 5 4 883 889
109. Branco M. R., Ficz G., Reik W. Uncovering the role of 5-hydroxymethylcytosine in the epigenome. Nat Rev Genet: 2012; 13 1 7 13
110. Haycock P. C., Ramsay M. Exposure of mouse embryos to ethanol during preimplantation development: effect on DNA methylation in the h19 imprinting control region. Biol Reprod: 2009; 81 4 618 627
111. Pirola L., Balcerczyk A., Tothill R. W., et al. Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells. Genome Res: 2011; 21 10 1601 1615
112. Goll M. G., Bestor T. H. Eukaryotic cytosine methyltransferases. Annu Rev Biochem: 2005; 74 481 514
113. Kamei Y., Suganami T., Ehara T., et al. Increased expression of DNA methyltransferase 3a in obese adipose tissue: studies with transgenic mice. Obesity (Silver Spring): 2010; 18 2 314 321
114. Gut P., Verdin E. The nexus of chromatin regulation and intermediary metabolism. Nature: 2013; 502 7472 489 498
115. Heijmans B. T., Tobi E. W., Lumey L. H., Slagboom P. E. The epigenome: archive of the prenatal environment. Epigenetics: 2009; 4 8 526 531
116. Tobi E. W., Lumey L. H., Talens R. P., et al. DNA methylation differences after exposure to prenatal famine are common and timing- and sex-specific. Hum Mol Genet: 2009; 18 21 4046 4053
117. Waterland R. A., Lin J. R., Smith C. A., Jirtle R. L. Post-weaning diet affects genomic imprinting at the insulin-like growth factor 2 (Igf2) locus. Hum Mol Genet: 2006; 15 5 705 716
118. Keyes M. K., Jang H., Mason J. B., et al. Older age and dietary folate are determinants of genomic and p16-specific DNA methylation in mouse colon. J Nutr: 2007; 137 7 1713 1717
119. Hoile S. P., Irvine N. A., Kelsall C. J., et al. Maternal fat intake in rats alters 20:4n-6 and 22:6n-3 status and the epigenetic regulation of Fads2 in offspring liver. J Nutr Biochem: 2013; 24 7 1213 1220
120. Hass B. S., Hart R. W., Lu M. H., Lyn-Cook B. D. Effects of caloric restriction in animals on cellular function, oncogene expression, and DNA methylation in vitro. Mutat Res: 1993; 295 4-6 281 289
121. Chen P. Y., Ganguly A., Rubbi L., et al. Intrauterine calorie restriction affects placental DNA methylation and gene expression. Physiol Genomics: 2013; 45 14 565 576